参考文献/References:
[1] 中华人民共和国国家卫生健康委员会医政医管局.原发性肝癌诊疗规范(2019年版)[J].中国实用外科杂志,2020,40(2):121-138.
[2] 闫东.2018《CSCO原发性肝癌诊疗指南》解读:肝动脉介入治疗部分[J].肝癌电子杂志,2018,5(3):4-7.
[3] IKEDA M,KUDO M,AIKATA H,et al.Transarterial chemoembolization with miriplatin vs.epirubicin for unresectable hepatocellular carcinoma:a phase III randomized trial[J].J Gastroenterol,2018,53(2):281-290.
[4] HUO Y R,ESLICK G D.Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma:a systematic review and meta-analysis[J].JAMA Oncol,2015,1(6):756-765.
[5] ZHANG A M,XIAO Z S,LIU Q F,et al.CaCO3-encapuslated microspheres for enhanced transhepatic arterial embolization treatment of hepatocellular carcinoma[J].Adv Healthc Mater,2021,10(19):e2100748.
[6] LYU N,LIN Y,KONG Y,et al.FOXAI:a phaseⅡtrial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma[J].Gut,2018,67(2):395-396.
[7] LEE K F,WONG J,HUI J W,et al.Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach:a retrospective comparative study[J].Asian J Surg,2017,40(4):301-308.
[8] THAMTORAWAT S,HICKS R M,YU J,et al.Preliminary outcome of microwave ablation of hepatocellular carcinoma:breaking the 3-cm barrier?[J].J Vasc Interv Radiol,2016,27(5):623-630.
[9] MELONI M F,GALIMBERTI S,DIETRICH C F,et al.Microwave ablation of hepatic tumors with a third generation system:loco-regional efficacy in a prospective cohort study with intermediate term follow-up[J].Z Gastroenterol,2016,54(6):541-547.
[10] LIANG P,YU J,LU M D,et al.Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy[J].World J Gastroenterol,2013,19(33):5430-5438.
[11] 张德耀,陈敏山.《2021年欧洲肿瘤内科学会肝细胞癌临床实践指南更新》解读[J].中国医学前沿杂志:电子版,2021,13(8):1-4.DOI:10.12037/YXQY.2021.08-01.
[12] 岳衍晓,宁尚昆,刘吉兵,等.晚期原发性肝癌介入治疗与联合靶向药物治疗效果对比分析[J].中华肿瘤防治杂志,2021,28(10):788-791.
[13] 王洪剑,谢军,刘臣臣,等.TACE联合微波消融术治疗中晚期肝细胞肝癌的疗效[J].川北医学院学报,2021,36(10):1305-1308.
[14] 冯含昕,赵阳,徐锋,等.微波消融技术在肝癌治疗的应用现状和展望[J].中华普通外科学文献:电子版,2020,14(6):458-462.DOI:10.3877/cma.j.issn.1674-0793.2020.06.016.
[15] 程远举,曹君航.肝动脉化疗栓塞术联合超声引导下微波消融术治疗邻近关键部位中晚期肝细胞癌的疗效与安全性观察[J].黑龙江医学,2021,45(5):456-458.
相似文献/References:
[1]丁肖华,毛恺,邱耕,等.反向点杂交检测肝癌细胞DNA 甲基化方法的建立[J].新乡医学院学报,2012,29(01):000.
[2]邱颖谦,陈永林.微小RNA在肝细胞肝癌中的作用研究进展[J].新乡医学院学报,2020,37(9):893.[doi:10.7683/xxyxyxb.2020.09.021]
[3]苏天琳,王中会,晁 旭,等.常规超声联合血清甲胎蛋白评估改良二乙基亚硝胺给药法诱导大鼠肝细胞肝癌模型的可行性[J].新乡医学院学报,2022,39(8):708.[doi:10.7683/xxyxyxb.2022.08.002]
SU Tianlin,WANG Zhonghui,CHAO Xu,et al.Feasibility of conventional ultrasound combined with serum alpha-fetoprotein in the evaluation of modified diethylnitrosamine administration induced hepatocellular liver cancer model in rats[J].Journal of Xinxiang Medical University,2022,39(12):708.[doi:10.7683/xxyxyxb.2022.08.002]
[4]文正燕,孙传俊,杨献光.混合谱系激酶结构域样蛋白、caspase-8及受体相互作用蛋白激酶3 mRNA在不同阶段乙型肝炎病毒感染患者中的表达及诊断价值[J].新乡医学院学报,2023,40(7):628.[doi:10.7683/xxyxyxb.2023.07.005]
WEN Zhengyan,SUN Chuanjun,YANG Xianguang.Expression and diagnostic value of mixed lineage kinase domainlike protein,caspase8 and receptor interacting protein kinase 3 mRNA in patients at different stages of hepatitis B virus infection[J].Journal of Xinxiang Medical University,2023,40(12):628.[doi:10.7683/xxyxyxb.2023.07.005]